Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine☆

[1]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  I. Zidi,et al.  Nanoparticles targeting HLA-G for gene therapy in cancer , 2012, Medical Oncology.

[3]  Jaap M Middeldorp,et al.  Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. , 2011, Biochimica et biophysica acta.

[4]  W. Hammerschmidt,et al.  EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL , 2011, PloS one.

[5]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[6]  M. Wood,et al.  Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  Y. Kaneda.  HVJ liposomes and HVJ envelope vectors. , 2011, Cold Spring Harbor protocols.

[8]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[9]  H. Petry,et al.  In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs , 2011, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.

[10]  V. Petrenko,et al.  Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[11]  T. Wurdinger,et al.  LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF‐κB activation , 2011, The EMBO journal.

[12]  Gunther Hartmann,et al.  SiRNA delivery with exosome nanoparticles , 2011, Nature Biotechnology.

[13]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[14]  M. Zöller,et al.  Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. , 2011, Biochemical Society transactions.

[15]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[16]  Susanne Gabrielsson,et al.  Exosomes Containing Glycoprotein 350 Released by EBV-Transformed B Cells Selectively Target B Cells through CD21 and Block EBV Infection In Vitro , 2011, The Journal of Immunology.

[17]  J. Martinez-Picado,et al.  Exosomes and retroviruses: the chicken or the egg? , 2011, Cellular microbiology.

[18]  H. Greenberg,et al.  Membrane vesicles released by intestinal epithelial cells infected with rotavirus inhibit T-cell function. , 2010, Viral immunology.

[19]  S. Mathivanan,et al.  Exosomes: extracellular organelles important in intercellular communication. , 2010, Journal of proteomics.

[20]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[22]  D Michiel Pegtel,et al.  Exosomes: Fit to deliver small RNA. , 2010, Communicative & integrative biology.

[23]  O. Voinnet,et al.  Control of RNA silencing and localization by endolysosomes. , 2010, Trends in cell biology.

[24]  Yang Zhang,et al.  DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. , 2010, International journal of pharmaceutics.

[25]  D. Dykxhoorn,et al.  Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.

[26]  P. Benaroch,et al.  HIV-1 assembly in macrophages , 2010, Retrovirology.

[27]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[28]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[29]  Jan Delabie,et al.  Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma , 2010, Nature.

[30]  S. Temme,et al.  The Herpes Simplex Virus-1 Encoded Glycoprotein B Diverts HLA-DR into the Exosome Pathway , 2009, The Journal of Immunology.

[31]  B. Berkhout,et al.  Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[33]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[34]  H. Stenmark.  Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.

[35]  A. Brech,et al.  Multivesicular Endosome Biogenesis in the Absence of ESCRTs , 2009, Traffic.

[36]  M. Wood,et al.  Biological gene delivery vehicles: beyond viral vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  G. Melikyan,et al.  HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes , 2009, Cell.

[38]  R. Sougrat,et al.  Human Immunodeficiency Virus Type 1 Nef Protein Targets CD4 to the Multivesicular Body Pathway , 2009, Journal of Virology.

[39]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[40]  Jaap M Middeldorp,et al.  Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. , 2008, Seminars in cancer biology.

[41]  R. Simpson,et al.  Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.

[42]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[43]  Oliver Wildner,et al.  Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus , 2008, Vaccine.

[44]  Bradley C. Bundy,et al.  Escherichia coli‐based cell‐free synthesis of virus‐like particles , 2008, Biotechnology and bioengineering.

[45]  Petra Schwille,et al.  Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.

[46]  G. van Meer,et al.  No ESCRTs for Exosomes , 2008, Science.

[47]  J. Hurley,et al.  ESCRT complexes and the biogenesis of multivesicular bodies. , 2008, Current opinion in cell biology.

[48]  E. Miska,et al.  MicroRNA—implications for cancer , 2007, Virchows Archiv.

[49]  David T. Curiel,et al.  Engineering targeted viral vectors for gene therapy , 2007, Nature Reviews Genetics.

[50]  S. Gould,et al.  Higher-Order Oligomerization Targets Plasma Membrane Proteins and HIV Gag to Exosomes , 2007, PLoS biology.

[51]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[52]  Roger L. Williams,et al.  The emerging shape of the ESCRT machinery , 2007, Nature Reviews Molecular Cell Biology.

[53]  E. Ruiz-Mateos,et al.  In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53 , 2007, The Journal of cell biology.

[54]  K. Überla,et al.  Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies , 2007, Virology.

[55]  M. Hirashima,et al.  Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9 , 2006, BMC Cancer.

[56]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[57]  P. Choong,et al.  Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[58]  R. Johnstone,et al.  Exosomes biological significance: A concise review. , 2006, Blood cells, molecules & diseases.

[59]  Mark Marsh,et al.  Virus Entry: Open Sesame , 2006, Cell.

[60]  M. Kielian.  Class II virus membrane fusion proteins. , 2006, Virology.

[61]  J. Wilschut,et al.  The virosome concept for influenza vaccines. , 2005, Vaccine.

[62]  Judy Lieberman,et al.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.

[63]  W. Greene,et al.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells , 2005, Nature.

[64]  R. Johnstone.  Revisiting the road to the discovery of exosomes. , 2005, Blood cells, molecules & diseases.

[65]  J. Lieberman,et al.  The prospect of silencing disease using RNA interference. , 2005, JAMA.

[66]  R. Russell,et al.  Principles of MicroRNA–Target Recognition , 2005, PLoS biology.

[67]  John Guatelli,et al.  Nef-induced Alteration of the Early/Recycling Endosomal Compartment Correlates with Enhancement of HIV-1 Infectivity* , 2005, Journal of Biological Chemistry.

[68]  Aimee L Jackson,et al.  Noise amidst the silence: off-target effects of siRNAs? , 2004, Trends in genetics : TIG.

[69]  M. Houghton,et al.  Association of hepatitis C virus envelope proteins with exosomes , 2004, European journal of immunology.

[70]  A. Levitzki,et al.  RNA molecules as anti-cancer agents. , 2004, Seminars in cancer biology.

[71]  G. Raposo,et al.  Endosomes, exosomes and Trojan viruses. , 2004, Trends in microbiology.

[72]  F. Natt,et al.  siRNA relieves chronic neuropathic pain. , 2004, Nucleic acids research.

[73]  D. Dimitrov,et al.  Virus entry: molecular mechanisms and biomedical applications , 2004, Nature Reviews Microbiology.

[74]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[75]  W. Sundquist,et al.  The Protein Network of HIV Budding , 2003, Cell.

[76]  P. Roy,et al.  Virus-like particles as immunogens. , 2003, Trends in microbiology.

[77]  A. Booth,et al.  The Trojan exosome hypothesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[78]  A. Kondo,et al.  Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.

[79]  David R Corey,et al.  RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.

[80]  Jaap M Middeldorp,et al.  Localization of the Epstein-Barr virus protein LMP 1 to exosomes. , 2003, The Journal of general virology.

[81]  Kinam Park,et al.  Polycation gene delivery systems: escape from endosomes to cytosol , 2003, The Journal of pharmacy and pharmacology.

[82]  J. Slot,et al.  Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.

[83]  T. Söllner,et al.  Regulated exocytosis and SNARE function (Review) , 2003, Molecular membrane biology.

[84]  D. Baltimore,et al.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  S. Emr,et al.  Receptor downregulation and multivesicular-body sorting , 2002, Nature Reviews Molecular Cell Biology.

[86]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[87]  G. Whittaker,et al.  Dissecting virus entry via endocytosis. , 2002, The Journal of general virology.

[88]  Graça Raposo,et al.  The Biogenesis and Functions of Exosomes , 2002, Traffic.

[89]  P. Coursaget,et al.  Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. , 2001, The Journal of general virology.

[90]  M. D. Brown,et al.  Gene delivery with synthetic (non viral) carriers. , 2001, International journal of pharmaceutics.

[91]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[92]  J. Lifson,et al.  MHC-I–restricted presentation of HIV-1 virion antigens without viral replication , 2001, Nature Medicine.

[93]  H. Pelham.  SNAREs and the specificity of membrane fusion. , 2001, Trends in cell biology.

[94]  E. Bloemena,et al.  Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1 , 2000, The Journal of Immunology.

[95]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[96]  P. Stewart,et al.  Role of αv Integrins in Adenovirus Cell Entry and Gene Delivery , 1999, Microbiology and Molecular Biology Reviews.

[97]  H. Geuze,et al.  Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.

[98]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[99]  Somesh D. Sharma,et al.  The Macrophages , 1986, Clinics in Immunology and Allergy.

[100]  T. Greenwalt,et al.  Human erythrocytes shed exocytic vesicles in vivo , 1984, Transfusion.

[101]  V. Bond,et al.  HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. , 2008, Ethnicity & disease.

[102]  F. Rey,et al.  Virus membrane-fusion proteins: more than one way to make a hairpin , 2006, Nature Reviews Microbiology.

[103]  S. Barik,et al.  Inhibition of respiratory viruses by nasally administered siRNA , 2005, Nature Medicine.

[104]  E. Freed,et al.  Retrovirus budding. , 2004, Virus research.

[105]  P. Stewart,et al.  Role of alpha(v) integrins in adenovirus cell entry and gene delivery. , 1999, Microbiology and molecular biology reviews : MMBR.